Androgen receptor activation by G(s) signaling in prostate cancer cells

J Biol Chem. 2005 Mar 25;280(12):11583-9. doi: 10.1074/jbc.M414423200. Epub 2005 Jan 14.

Abstract

The androgen receptor (AR) is activated in prostate cancer patients undergoing androgen ablative therapy and mediates growth of androgen-insensitive prostate cancer cells, suggesting it is activated by nonandrogenic factors. We demonstrate that activated alpha subunit of heterotrimeric guanine nucleotide-binding G(s) protein activates the AR in prostate cancer cells and also synergizes with low concentration of androgen to more fully activate the AR. The G alpha(s) activates protein kinase A, which is required for the nuclear partition and activation of AR. These data suggest a role for G alpha(s) and PKA in the transactivation of AR in prostate cancer cells under the environment of reduced androgen levels.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Cyclic AMP / physiology
  • Cyclic AMP-Dependent Protein Kinases / physiology
  • Dihydrotestosterone / pharmacology
  • GTP-Binding Protein alpha Subunits, Gs / physiology*
  • Humans
  • Isoproterenol / pharmacology
  • Male
  • Prostatic Neoplasms / metabolism*
  • Prostatic Neoplasms / pathology
  • Receptors, Adrenergic, beta-2 / physiology
  • Receptors, Androgen / physiology*
  • Signal Transduction / physiology*

Substances

  • Receptors, Adrenergic, beta-2
  • Receptors, Androgen
  • Dihydrotestosterone
  • Cyclic AMP
  • Cyclic AMP-Dependent Protein Kinases
  • GTP-Binding Protein alpha Subunits, Gs
  • Isoproterenol